新型 CMT 酶 TEM-154 的特性分析。
Characterization of the Novel CMT Enzyme TEM-154.
机构信息
Laboratoire de Bactériologie, Faculté de Médecine, 28 Place H. Dunant, 63001 Clermont-Ferrand, France.
出版信息
Antimicrob Agents Chemother. 2011 Mar;55(3):1262-5. doi: 10.1128/AAC.01359-10. Epub 2010 Dec 20.
Abstract
TEM-154, identified in Portugal in 2004, associated the substitutions observed in the extended-spectrum β-lactamase (ESBL) TEM-12 and in the inhibitor-resistant penicillinase (IRT) TEM-33. This enzyme exhibited hydrolytic activity against ceftazidime and a low level of resistance to clavulanic acid. Surprisingly, the substitution Met69Leu enhanced the catalytic efficiency of oxyimino β-lactams conferred by the substitution Arg164Ser. Its discovery confirms the dissemination of the complex mutant group of TEM enzymes in European countries.
摘要
TEM-154 于 2004 年在葡萄牙被鉴定，其结合了在扩展谱β-内酰胺酶（ESBL）TEM-12 和抑制剂抗性青霉素酶（IRT）TEM-33 中观察到的取代。这种酶对头孢他啶具有水解活性，并且对克拉维酸的耐药性较低。令人惊讶的是，取代 Met69Leu 增强了由取代 Arg164Ser 赋予的肟型β-内酰胺的催化效率。它的发现证实了 TEM 酶的复杂突变体群在欧洲国家的传播。
相似文献
1
Characterization of the Novel CMT Enzyme TEM-154.新型 CMT 酶 TEM-154 的特性分析。
Antimicrob Agents Chemother. 2011 Mar;55(3):1262-5. doi: 10.1128/AAC.01359-10. Epub 2010 Dec 20.
2
TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.TEM-121，一种来自产气肠杆菌的新型TEM型β-内酰胺酶复合突变体。
Antimicrob Agents Chemother. 2004 Dec;48(12):4528-31. doi: 10.1128/AAC.48.12.4528-4531.2004.
3
TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).TEM-109（CMT-5），一种TEM-1β-内酰胺酶的天然复合突变体，结合了TEM-6和TEM-33（IRT-5）的氨基酸替换。
Antimicrob Agents Chemother. 2005 Nov;49(11):4443-7. doi: 10.1128/AAC.49.11.4443-4447.2005.
4
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.TEM-158（CMT-9），CMT型超广谱β-内酰胺酶的一个新成员。
Antimicrob Agents Chemother. 2007 Nov;51(11):4181-3. doi: 10.1128/AAC.00614-07. Epub 2007 Aug 20.
5
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.在一种来自产气肠杆菌和粘质沙雷氏菌临床分离株的新型天然TEM型超广谱β-内酰胺酶TEM-149中，E240V替代增加了对头孢他啶的催化效率。
Antimicrob Agents Chemother. 2008 Mar;52(3):915-9. doi: 10.1128/AAC.01028-07. Epub 2007 Dec 26.
6
Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.构建并鉴定含有与超广谱耐药性和对β-内酰胺酶抑制剂耐药性相关氨基酸取代的TEM-1β-内酰胺酶突变体。
Antimicrob Agents Chemother. 1999 Aug;43(8):1881-7. doi: 10.1128/AAC.43.8.1881.
7
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.TEM 型酶的进化：来自一名患者的两种新型复合突变 TEM 酶 TEM-151 和 TEM-152 的生化及遗传学特征分析
Antimicrob Agents Chemother. 2007 Apr;51(4):1304-9. doi: 10.1128/AAC.01058-06. Epub 2007 Jan 12.
8
X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.大肠杆菌TEM-1 β-内酰胺酶Asn276Asp变体的X射线结构：直接观察对克拉维酸失活抗性中的静电调节
Biochemistry. 1999 Jul 27;38(30):9570-6. doi: 10.1021/bi990758z.
9
Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.一种独特的头孢他啶水解β-内酰胺酶TEM-E2的特性分析。
J Med Microbiol. 1990 Jun;32(2):131-4. doi: 10.1099/00222615-32-2-131.
10
A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.一种新的源自透射电子显微镜（TEM）的超广谱β-内酰胺酶（TEM-91），其ω-环处发生R164C取代，赋予了对头孢他啶的耐药性。
Antimicrob Agents Chemother. 2003 Sep;47(9):2981-3. doi: 10.1128/AAC.47.9.2981-2983.2003.
引用本文的文献
1
Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa.非洲耐碳青霉烯类和多黏菌素类大肠埃希菌和肺炎克雷伯菌重叠威胁的回顾与分析。
Antimicrob Resist Infect Control. 2023 Apr 4;12(1):29. doi: 10.1186/s13756-023-01220-4.
2
Evolution of CTX-M-215, a Novel Narrow-Spectrum β-Lactamase in an Escherichia coli Clinical Isolate Conferring Resistance to Mecillinam.CTX-M-215 的进化，一种新型窄谱β-内酰胺酶，在一株对美西林耐药的大肠杆菌临床分离株中发现。
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.00562-20.
3
Detection of the Gene in a Multidrug-Resistant Escherichia coli Isolate from an Austrian Patient.在一名奥地利患者的多重耐药性大肠杆菌分离株中检测该基因。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02623-16. Print 2017 Apr.
4
CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate.CTX-M-190，一种对他唑巴坦和舒巴坦耐药的新型β-内酰胺酶，在一株大肠埃希菌临床分离株中被鉴定出来。
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01848-16. Print 2017 Jan.
本文引用的文献
1
High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.葡萄牙肠杆菌科临床分离株中广谱β-内酰胺酶的高度多样性。
J Antimicrob Chemother. 2007 Dec;60(6):1370-4. doi: 10.1093/jac/dkm381. Epub 2007 Oct 3.
2
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.TEM-158（CMT-9），CMT型超广谱β-内酰胺酶的一个新成员。
Antimicrob Agents Chemother. 2007 Nov;51(11):4181-3. doi: 10.1128/AAC.00614-07. Epub 2007 Aug 20.
3
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.TEM 型酶的进化：来自一名患者的两种新型复合突变 TEM 酶 TEM-151 和 TEM-152 的生化及遗传学特征分析
Antimicrob Agents Chemother. 2007 Apr;51(4):1304-9. doi: 10.1128/AAC.01058-06. Epub 2007 Jan 12.
4
CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.CMT型β-内酰胺酶TEM-125，是超广谱β-内酰胺酶检测面临的一个新问题。
Antimicrob Agents Chemother. 2006 Jul;50(7):2403-8. doi: 10.1128/AAC.01639-05.
5
TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).TEM-109（CMT-5），一种TEM-1β-内酰胺酶的天然复合突变体，结合了TEM-6和TEM-33（IRT-5）的氨基酸替换。
Antimicrob Agents Chemother. 2005 Nov;49(11):4443-7. doi: 10.1128/AAC.49.11.4443-4447.2005.
6
TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.TEM-121，一种来自产气肠杆菌的新型TEM型β-内酰胺酶复合突变体。
Antimicrob Agents Chemother. 2004 Dec;48(12):4528-31. doi: 10.1128/AAC.48.12.4528-4531.2004.
7
A transient tobacco expression system coupled to MALDI-TOF-MS allows validation of the impact of differential targeting on structure and activity of a recombinant therapeutic glycoprotein produced in plants.与基质辅助激光解吸电离飞行时间质谱联用的瞬时烟草表达系统，能够验证差异靶向对植物中产生的重组治疗性糖蛋白的结构和活性的影响。
FEBS Lett. 2003 Sep 25;552(2-3):170-6. doi: 10.1016/s0014-5793(03)00916-5.
8
TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.奇异变形杆菌临床分离株产生的TEM-89β-内酰胺酶：一种新型复合突变体（CMT 3），在TEM-59（IRT-17）和TEM-3中均有突变。
Antimicrob Agents Chemother. 2001 Dec;45(12):3591-4. doi: 10.1128/AAC.45.12.3591-3594.2001.
9
Updated sequence information and proposed nomenclature for bla(TEM) genes and their promoters.bla(TEM)基因及其启动子的更新序列信息和建议命名法。
Antimicrob Agents Chemother. 2000 Nov;44(11):3232-4. doi: 10.1128/AAC.44.11.3232-3234.2000.
10
A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil.在巴西分离出的粘质沙雷氏菌中发现的一种新型A类超广谱β-内酰胺酶（BES-1）。
Antimicrob Agents Chemother. 2000 Nov;44(11):3061-8. doi: 10.1128/AAC.44.11.3061-3068.2000.
Zotero 插件